Lilly says diabetes drug Trulicity reduces heart risks in trial
The company did not provide any details on the magnitude of risk reduction seen in the so-called outcomes trial
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
bioLIVE to merge with BioProduction Congress for 2019 event
BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the…
Sanofi and Regeneron’s Dupixent gets more positive feedback from US FDA
Dupixent was launched in the US in April 2017 for the treatment of moderate-to-severe eczema
The US Food & Drug…
Cipla posts ₹ 377 crore PAT in Q2FY19
The company's income from operations was at Rs 4012 crore
Unichem and Optimus enter into a strategic tie-up
Unichem and Optimus company has entered into an agreement to acquire 20 per cent equity stake in the API
Suven Life Sciences gets product patents from Israel, Japan
These patents are valid through 2036 and 2034 respectively
Dishman Carbogen Amcis announces successful FDA inspection
The company's site in Bavla underwent five-day inspection
Natco Pharma posts over two-fold jump in Q2 PAT to ₹ 181.6 crore
The company had posted a consolidated profit after tax of ₹ 84.4 crore in the same quarter
National seminar on entrepreneurship and business development in Ayurveda held in New Delhi
The seminar was organised by Ministry of AYUSH in association with NITI Aayog with the aim of encouraging entrepreneurs and…
Torrent Pharma Q2 net profit dips 12% to ₹ 179 crore
The consolidated revenue, however, rose to ₹ 1,894 crore for the quarter under consideration as against Rs 1,417 crore
Torrent…